Overview
- TickerBMEZ on NYSE2
- HeadquartersWilmington, United States2
- Incorporated inMD3
- Business address100 Bellevue Parkway, Wilmington, De 198093
- Legal formTrust2
- Kind of organizationFund2
- LEI549300FGMK4EGHSK8N862
- StatusActive2
- LEI statusIssued and current2
- Registered addressc/o THE CORPORATION TRUST INCORPORATED, 2405 YORK ROAD, SUITE 201, 21093-2264 Lutherville Timonium, United States2
- Registered withBusiness Services (Maryland Department of Assessments and Taxation), B198761352
Corporate structure
BlackRock Health Sciences Term Trust sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of BlackRock Health Sciences Term Trust
- Saba Capital Management, L.P. Filed SCHEDULE 13D/A on BlackRock Health Sciences Term Trust, latest Jan 21, 2025 (16 filings since May 26, 2023)
- Morgan Stanley Filed SC 13G/A on BlackRock Health Sciences Term Trust, latest Dec 12, 2022 (2 filings since Feb 9, 2022)
- BlackRock Health Sciences Term Trust Wilmington, Delaware, United States
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
Leadership
Who has led BlackRock Health Sciences Term Trust, and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
- Chief executive officerJohn Perlowski Jan 28, 2020 to Jan 28, 20204
- PresidentJohn Perlowski Jan 28, 2020 to Jan 28, 20204
- Chief financial officerTrent Walker Jan 12, 2021 to Jan 12, 20215
- Chief financial officerNeal Andrews Jan 28, 2020 to Jan 28, 20206
Board members and other officers (22)
- Vice PresidentStephen Thomas Minar May 16, 2025 to now7
- Chief Compliance OfficerAaron David Wasserman Jul 6, 2023 to Jul 6, 20238
- Chief Compliance OfficerCharles Park Jan 28, 2020 to now9
- SecretaryJaney Ahn Jan 28, 2020 to Jan 28, 202010
- TreasurerJay M. Fife Jan 28, 2020 to Jan 28, 202011
- Vice PresidentJonathan Diorio Jan 28, 2020 to Jan 28, 202012
- Board memberFrancis C. Mahoney Sep 17, 2026 to now13
- Board memberArthur Philip Steinmetz Sep 14, 2023 to Sep 14, 202314
- Board memberJames Phillip Holloman Jun 21, 2021 to Jun 21, 202115
- Board memberStayce Harris Jun 21, 2021 to Jun 21, 202116
- Board memberLorenzo Flores Aug 9, 2021 to Aug 9, 202117
- Board memberCarl W. Kester Jan 28, 2020 to Jan 28, 202018
- Board memberCatherine A. Lynch Jan 28, 2020 to Jan 28, 202019
- Board memberCynthia Egan Jan 28, 2020 to Dec 23, 202020
- Board memberFrank Fabozzi Jan 28, 2020 to Jan 28, 202021
- Board memberHenry Gabbay Jan 28, 2020 to Jan 28, 202022
- Board memberJohn Perlowski Jan 28, 2020 to Jan 28, 20204
- Board memberKaren P. Robards Jan 28, 2020 to Feb 20, 202023
- Board memberMichael J. Castellano Jan 28, 2020 to Jan 28, 202024
- Board memberRichard Cavanagh Jan 28, 2020 to Feb 25, 202025
- Board memberRobert Glenn Hubbard Jan 28, 2020 to Jan 28, 202026
- Board memberRobert W. Fairbairn Jan 28, 2020 to now27
Former names
- BlackRock Health Sciences Trust IIAug 20, 2019 to Mar 24, 20233
Timeline
Filings
227 filings to the SEC since October 2021: 76 insider forms, 18 large holders, 133 other. The latest 20:
- Oct 1, 2026SC TO-C EDGAR
- Sep 17, 20263 EDGAR
- Sep 3, 2026N-CSRS BLACKROCK HEALTH SCIENCES TERM TRUST EDGAR
- Aug 28, 2026N-PX EDGAR
- Aug 25, 2026NPORT-P EDGAR
- Aug 5, 20263 EDGAR
- May 28, 2026NPORT-P EDGAR
- Mar 13, 2026N-CEN EDGAR
- Mar 5, 2026N-CSR BLACKROCK HEALTH SCIENCES TERM TRUST EDGAR
- Feb 24, 2026NPORT-P EDGAR
- Feb 3, 20264 EDGAR
- Feb 3, 20264 EDGAR
- Dec 22, 20254 EDGAR
- Nov 26, 2025NPORT-P EDGAR
- Sep 4, 2025N-CSRS BLACKROCK HEALTH SCIENCES TERM TRUST EDGAR
- Aug 28, 2025N-PX EDGAR
- Aug 26, 2025NPORT-P EDGAR
- May 28, 2025NPORT-P EDGAR
- May 16, 20253 EDGAR
- Apr 22, 20254 PRIMARY DOCUMENT EDGAR
The 227 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
98 open-market trades by officers, directors and large owners since October 2021: 96 buys and 2 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Dec 19, 2025 | Fairbairn Robert WDirector | Sale | 1 | $14.96 | $13 | Form 4 |
| Dec 18, 2025 | Fairbairn Robert WDirector | Sale | 20,588 | $14.98 | $308.4K | Form 4 |
| Oct 16, 2024 | Weinstein Boaz10% owner | Buy | 29,795 | $15.81 | $471.1K | Form 4 |
| Oct 15, 2024 | Weinstein Boaz10% owner | Buy | 34,921 | $15.81 | $552.1K | Form 4 |
| Oct 14, 2024 | Saba Capital Management, L.P.10% owner | Buy | 15,281 | $15.87 | $242.5K | Form 4 |
| Oct 1, 2024 | Weinstein Boaz10% owner | Buy | 9,526 | $15.79 | $150.4K | Form 4 |
| Sep 30, 2024 | Saba Capital Management, L.P.10% owner | Buy | 8,012 | $15.84 | $126.9K | Form 4 |
| Sep 27, 2024 | Weinstein Boaz10% owner | Buy | 1,633 | $15.89 | $25.9K | Form 4 |
| Sep 26, 2024 | Weinstein Boaz10% owner | Buy | 47,871 | $15.81 | $756.8K | Form 4 |
| Sep 25, 2024 | Weinstein Boaz10% owner | Buy | 300 | $15.73 | $4.7K | Form 4 |
| Sep 23, 2024 | Saba Capital Management, L.P.10% owner | Buy | 2,006 | $15.98 | $32.1K | Form 4 |
| Sep 19, 2024 | Weinstein Boaz10% owner | Buy | 15,455 | $16.14 | $249.4K | Form 4 |
| Sep 18, 2024 | Saba Capital Management, L.P.10% owner | Buy | 20,534 | $15.88 | $326.1K | Form 4 |
| Sep 17, 2024 | Saba Capital Management, L.P.10% owner | Buy | 27,148 | $15.93 | $432.5K | Form 4 |
| Apr 1, 2024 | Weinstein Boaz10% owner | Buy | 46,421 | $16.33 | $758.1K | Form 4 |
| Mar 28, 2024 | Weinstein Boaz10% owner | Buy | 16,297 | $16.33 | $266.1K | Form 4 |
| Mar 26, 2024 | Saba Capital Management, L.P.10% owner | Buy | 129,372 | $16.32 | $2.1M | Form 4 |
| Mar 6, 2024 | Weinstein Boaz10% owner | Buy | 13,781 | $16.28 | $224.4K | Form 4 |
| Mar 1, 2024 | Saba Capital Management, L.P.10% owner | Buy | 112,050 | $16.49 | $1.8M | Form 4 |
| Feb 29, 2024 | Saba Capital Management, L.P.10% owner | Buy | 46,958 | $16.30 | $765.4K | Form 4 |
All 98 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Saba Capital Management, L.P.SCHEDULE 13D/A, 16 filings May 26, 2023 to Jan 21, 202528
- Morgan StanleySC 13G/A, 2 filings Feb 9, 2022 to Dec 12, 202229
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 87. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Morgan Stanley | 1,794,694 | $27.5M | 0.0% | −144,315 |
| Bank Of America Corp /de/ | 1,400,541 | $21.5M | 0.0% | +87,331 |
| Saba Capital Management, L.P. | 1,348,202 | $20.7M | 0.6% | +588,696 |
| Lazard Asset Management LLC | 1,332,867 | $20.5M | 0.0% | +711,263 |
| Raymond James Financial Inc | 1,105,575 | $17.0M | 0.0% | +140,869 |
| UBS Group AG | 1,064,856 | $16.3M | 0.0% | +55,844 |
| Invesco Ltd. | 885,405 | $13.6M | 0.0% | −84,138 |
| Rivernorth Capital Management, LLC | 873,816 | $13.4M | 0.6% | +64,620 |
| Wells Fargo & Company/mn | 780,232 | $12.0M | 0.0% | +1,445 |
| Almitas Capital LLC | 507,095 | $7.8M | 1.9% | +700 |
| City Of London Investment Management Co Ltd | 503,273 | $7.7M | 0.5% | No change |
| Atlas Wealth LLC | 499,696 | $7.7M | 1.1% | New |
| 1607 Capital Partners, LLC | 442,213 | $6.8M | 0.6% | −72,260 |
| Z3 Capital Partners, LLC | 393,512 | $6.0M | 1.3% | +27,142 |
| Royal Bank Of Canada | 341,103 | $5.2M | 0.0% | −12,502 |
| Stifel Financial Corp | 224,529 | $3.4M | 0.0% | −26,119 |
| Blue Bell Private Wealth Management, LLC | 177,065 | $2.7M | 0.3% | +19,175 |
| LPL Financial LLC | 171,681 | $2.6M | 0.0% | −24,359 |
| Osaic Holdings, Inc. | 145,680 | $2.2M | 0.0% | +8,476 |
| Karpus Management, Inc. | 117,615 | $1.8M | 0.1% | −60 |
| Rockefeller Capital Management L.P. | 114,378 | $1.8M | 0.0% | −12,919 |
| RFG Advisory, LLC | 8,068 | $1.6M | 0.0% | −17,132 |
| Oppenheimer & Co Inc | 100,113 | $1.5M | 0.0% | +911 |
| Evolve Private Wealth, LLC | 93,692 | $1.4M | 0.1% | +11,387 |
| TrueMark Investments, LLC | 88,556 | $1.4M | 0.2% | +29,360 |
13F reports cover disclosed long positions in U.S. stocks only.
Members of Congress who traded it
1 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.
| Date | Member | Trade | Amount | Vs S&P since | Filing |
|---|---|---|---|---|---|
| Jan 29, 2020 | John HoevenRepublican, Senate | Buy | $100,001 - $250,000 | −155.0% | Report |
Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).
SEC filer profile
How BlackRock Health Sciences Term Trust is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARBlackRock Health Sciences Term Trust1
- CIK0001785971
- Incorporated inMaryland1
- Fiscal year endsDecember 311
- Business address100 Bellevue Parkway, Wilmington, DE 198091
- Phone800 882 00521
- On EDGAR sinceAug 20, 20191
- Filings300 in all: 4 (74), DFAN14A (34), 3 (33), DEFA14A (30), NPORT-P (26), SC 13D/A (14), 40-17G (8), CORRESP (8)1
All 36 form types
N-CSRS (7), N-PX (7), DEF 14A (6), N-CEN (6), N-CSR (6), SC TO-I/A (6), SC TO-C (5), N-2/A (3), PREC14A (3), SC TO-I (3), DEFC14A (2), DEFR14A (2), SC 13G/A (2), 4/A (1), 40-17G/A (1), 497 (1), 8-A12B (1), 8-K (1), CERT (1), DFRN14A (1), EFFECT (1), N-2 (1), N-2MEF (1), N-8A (1), SC 13D (1), SC 13G (1), SCHEDULE 13D/A (1), UPLOAD (1)
- Latest filingsProxy statement (DEF 14A) Jun 2, 2026
Latest 8-K (8-K) Mar 16, 2020
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7SEC EDGARStephen Thomas Minar, Vice President
- 8
- 9
- 10SEC EDGARJaney Ahn, Secretary
- 11SEC EDGARJay M. Fife, Treasurer
- 12SEC EDGARJonathan Diorio, Vice President
- 13SEC EDGARFrancis C. Mahoney, Board member
- 14
- 15SEC EDGARJames Phillip Holloman, Board member
- 16SEC EDGARStayce Harris, Board member
- 17SEC EDGARLorenzo Flores, Board member
- 18SEC EDGARCarl W. Kester, Board member
- 19SEC EDGARCatherine A. Lynch, Board member
- 20SEC EDGARCynthia Egan, Board member
- 21SEC EDGARFrank Fabozzi, Board member
- 22SEC EDGARHenry Gabbay, Board member
- 23SEC EDGARKaren P. Robards, Board member
- 24SEC EDGARMichael J. Castellano, Board member
- 25SEC EDGARRichard Cavanagh, Board member
- 26SEC EDGARRobert Glenn Hubbard, Board member
- 27SEC EDGARRobert W. Fairbairn, Board member
- 28
- 29